Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Economic evaluation of radiotherapy: methods and results].

Isabelle Durand-Zaleski1

  • 1Service de santé publique, hôpital Henri-Mondor, AP-HP, Créteil, France. i.durand-zaleski@anaes.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|October 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost Analysis of Mobile Phone Teledentistry in Dental Treatment Planning in Pediatric Care in the United Arab Emirates.

International journal of clinical pediatric dentistry·2026
Same author

Impact of an intervention standardizing the perinatal management of extremely preterm infants on the child's survival without severe morbidity: a stepped-wedge cluster-randomized trial (PREMEX study).

BMC pregnancy and childbirth·2026
Same author

Impact of first-trimester preeclampsia screening on perinatal and maternal morbidity: the RANSPRE open multicenter randomized trial.

BMC pregnancy and childbirth·2026
Same author

Prevention of secondary infections by interferon-gamma in ICU-acquired sustained immune suppression in France: study protocol of the PLATINIUM randomised trial.

BMJ open·2026
Same author

Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy.

Archives of cardiovascular diseases·2026
Same author

Medical devices for professional use: What assessment, what funding?

Therapie·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Cone-beam computed tomography-based radiomics for tumour regression assessment during radiotherapy of non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Radiotherapy in France costs €1700 per patient, significantly less than the European average. This cancer treatment offers 6-10 months of extended life, with cost-effectiveness between €5,000-€25,000 per life-year gained.

Area of Science:

  • Oncology
  • Health Economics

Context:

  • Radiotherapy is a crucial cancer treatment for 150,000 new patients annually in France.
  • The cost of radiotherapy in France is approximately €1700 per patient, which is 50% lower than the European average.
  • Economic evaluations often link radiotherapy costs to patient outcomes, considering both curative and palliative care.

Purpose:

  • To evaluate the cost-effectiveness of radiotherapy in France.
  • To assess the economic impact of radiotherapy in relation to patient survival benefits.

Summary:

  • Radiotherapy treatment in France is estimated at €1700 per patient, substantially below the European average.
  • For specific cancers like lung, rectal, breast, and prostate bone metastases, radiation therapy can extend survival by an estimated 6 to 10 months.

Related Experiment Videos

  • The cost-effectiveness of this life extension ranges from €5,000 to €25,000 per life-year gained.

    • Impact:

    • Provides crucial data for healthcare policy and resource allocation in oncology.
    • Highlights the economic value of radiotherapy in improving patient survival and quality of life.
    • Informs future economic analyses of cancer treatments in European healthcare systems.